AETOSWire - AETOSWire

العربية

Home
About us
- About
- Partners
- Blog
Services
Newsroom
- All Press Releases
- Multimedia Newsroom
Contact
Account

العربية

Home
About us
- About
- Partners
- Blog
Services
Newsroom
- All Press Releases
- Multimedia Newsroom
Contact
Account

العربية

NewsRoom

Home
NewsRoom

Newsroom
Multimedia Newsroom

Thursday, 12. September 2024

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and...

Friday, 23. February 2024

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in...

Tuesday, 09. January 2024

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in...

Subscribe to our Newsletter

Enter your email and stay updated

www.satellite-stars.online

About

AETOSWire distributes your news swiftly across your target audiences to every corner of the world with the latest state-of-the-art technology and innovative solutions that give you the competitive edge you need to get ahead of the competition.

Address

Dubai Media City, Building 1, 3rd Floor, Office 312 P.O. Box 502342 Dubai, United Arab Emirates

+971 4 55 77 007

+971 4 55 77 008

info@aetoswire.com

Quick Links

About us

Services

Newsroom

My Account

Privacy
Terms Of Use
Sitemap

Your experience on this site will be improved by allowing cookies. Cookie Policy

NewsRoom

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and...

Neuraptive Therapeutics, Inc. Announces Positive 24-Week Data for NTX-001 in...

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in...

Search...

Search...